Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.040
-0.090 (-4.23%)
At close: Jun 5, 2026, 4:00 PM EDT
2.020
-0.020 (-1.00%)
After-hours: Jun 5, 2026, 7:58 PM EDT
Ceylon Cold Stores Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
39
Market Cap
367.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 850.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vanda Pharmaceuticals | 217.78M |
| Century Therapeutics | 109.16M |
| OmniAb | 28.94M |
| X4 Pharmaceuticals | 9.01M |
| Upstream Bio | 3.32M |
| Shattuck Labs | 1.00M |
| Artiva Biotherapeutics | 251.00K |
CMPX News
- 1 day ago - Compass Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 8 days ago - Compass Therapeutics to Participate in Upcoming June Investor Events - GlobeNewsWire
- 15 days ago - Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting - GlobeNewsWire
- 16 days ago - Compass Therapeutics Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 17 days ago - Compass Therapeutics Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 24 days ago - Compass Therapeutics to Participate in Upcoming May Investor Events - GlobeNewsWire
- 4 weeks ago - Compass Therapeutics reports Q1 EPS (10c), consensus (10c) - TheFly
- 4 weeks ago - Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update - GlobeNewsWire